Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News COMPASS Pathways Plc CMPS

Healthcare Biotechnology
Compass Pathways plc is a United Kingdom-based biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The Company is engaged in the development of psilocybin treatment, in which its investigational COMP360 psilocybin is administered in conjunction with psychological support, COMP360 psilocybin treatment. COMP360 is its proprietary... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:CMPS)

Compass Pathways to Participate in December Investor Conferences

Business Wire 1 day ago

Compass Pathways Announces Third Quarter 2024 Financial Results and Business Updates

Business Wire October 31, 2024

Compass Pathways to Announce Third Quarter Financial Results on October 31, 2024

Business Wire October 24, 2024

Compass Pathways to Participate in Cowen Psychedelics and Novel Mechanisms in Neuropsychiatry Summit

Business Wire September 23, 2024

Compass Pathways announces second quarter 2024 financial results and business highlights

GlobeNewswire August 1, 2024

Compass Pathways appoints Lori Englebert as Chief Commercial Officer

GlobeNewswire June 26, 2024

Compass Pathways Announces First Quarter 2024 Financial Results and Business Highlights

GlobeNewswire May 8, 2024

Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 study of COMP360 psilocybin in post-traumatic stress disorder

GlobeNewswire May 8, 2024

Compass Pathways establishes research collaboration with Mindful Health Solutions to inform the development of a scalable and cost-effective delivery model for investigational COMP360 psilocybin treatment

GlobeNewswire May 2, 2024
View More News ››

Opinion & Analysis (NDAQ:CMPS)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:CMPS)

Compass Pathways Plc (CMPS) Q3 2024 Earnings Call Transcript

Breaking News: $CMPS Compass Pathways Plc (CMPS) Q3 2024 Earnings Call Transcript2024-10-31 21:00:25 ET Image source: The Motley Fool...
whytestocks - October 31, 2024

Trend Tracker for (CMPS)

JUST IN: $CMPS Trend Tracker for (CMPS)2024-10-31 14:30:00 ET Stock Traders Daily has produced this trading report using a proprietary...
whytestocks - October 31, 2024

COMPASS Pathways plc: Advancing Psilocybin Therapy with Prom

http://beyondspx.com/2024/07/31/compass-pathways-plc-advancing-psilocybin-therapy-with-promising-ptsd-data-and-pivotal-trd-trials-on...
MikeTester - August 2, 2024

Should You Buy the Dip on Compass Pathways Stock?

NEWS: $CMPS Should You Buy the Dip on Compass Pathways Stock?2024-06-12 06:25:00 ET If you can do the mental work to separate your...
whytestocks - June 12, 2024

COMPASS Pathways announces publication of positive data from

NEWS: $CMPS COMPASS Pathways announces publication of positive data from treatment-resistant depression phase 2 clinical trial of...
whytestocks - July 17, 2023

Buy for me here, stock seems cheap.

Stage 3 trials
FukDaFed - February 22, 2022
View more Bullboard ››

Globex Mining Enterprises Inc.

Globex Mining Enterprises Inc.

Globex Mining Enterprises Inc. is a Canada-based company, which is focused exploration and development property bank which ...
View More »